Carl Zeiss Meditec AG has won a patent infringement action before the District Court of Düsseldorf/Germany against VSY Biotechnology BV and its exclusive distribution partner Fritz Ruck Ophthalmologische Systeme GmbH.
The Medical Technology Business Group of ZEISS is presenting EXTARO 300. It is poised to revolutionize and differentiate dental practices with Augmented Visualization, Digital Patient Communication and Single-Handed Operation.
The first ReLEx SMILE minimally-invasive laser eye surgery procedure has been performed in the United States with the ZEISS VisuMax femtosecond laser.
Carl Zeiss Meditec continued its growth trend in the first quarter of 2016/17. Revenue increased by 6.6 percent.
Carl Zeiss Meditec AG is the parent company of the Carl Zeiss Meditec Group which also includes other subsidiaries. The Group is the focus for most of the medical technology business group's activity within the ZEISS organisation. The company is listed on TecDAX of the German stock exchange.
Find out more on our coporate website.
Carl Zeiss Meditec AG Website